Thyro
Thyro, licence 80057653: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Viatrexx (8046255 Canada Inc)
- NPN or DIN-HM
- 80057653
- Status
- Active licence
- Licence date
- 26 January 2015
- Revision date
- Not provided
- Form
- Vaporisateur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sus scrofa Source : Hypophyse | 200.0 K | Not calculated |
| Sus scrofa Source : Glande surrénale | 6.0 X | Not calculated |
| Spongia tosta Source : Éponge de mer torréfiée | 200.0 K | Not calculated |
| Sus scrofa Source : Glande thyroïde | 6.0 X | Not calculated |
| Sus scrofa Source : Glande surrénale | 200.0 K | Not calculated |
| Fucus vesiculosus Source : Thalle en entier | 3.0 X | Not calculated |
| Fucus vesiculosus Source : Thalle en entier | 200.0 K | Not calculated |
| Iodium Source : Iode | 12.0 X | Not calculated |
| Iodium Source : Iode | 200.0 K | Not calculated |
| Sus scrofa Source : Parathyroïde | 6.0 X | Not calculated |
| Sus scrofa Source : Parathyroïde | 200.0 K | Not calculated |
| Sus scrofa Source : Hypophyse | 6.0 X | Not calculated |
| Sus scrofa Source : Rate | 6.0 X | Not calculated |
| Sus scrofa Source : Rate | 200.0 K | Not calculated |
| Spongia tosta Source : Éponge de mer torréfiée | 3.0 X | Not calculated |
| Sus scrofa Source : Thymus | 6.0 X | Not calculated |
| Sus scrofa Source : Thymus | 200.0 K | Not calculated |
| Sus scrofa Source : Glande thyroïde | 200.0 K | Not calculated |
Non-medicinal ingredients
Ethanol 20%
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 13.0 Année(s) | minimum: 1.0 Pulvérisateur ; maximum: 5.0 Pulvérisateur | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Organotherapy and Homepathic preparation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057653
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.